Latest News-Wuxi Biologics Mediaroom_Page

WuXi Biologics Statement

SHANGHAI, Feb. 8, 2022 /PRNewswire/ -- We have been made aware of a recent U.S. Commerce Department...

2022-02-08 11:08 3785

WuXi Biologics Completes GMP Inspection by South Korea's Ministry of Food and Drug Safety for Drug Substance Facility

* WuXi Biologics completes the first GMP inspection in 2022, demonstrating the company's premier ...

2022-01-18 10:50 2456

WuXi Biologics Launches a New GMP Commercial Drug Product Facility

* Enhances drug product services for projects at various stages, with an emphasis on late and com...

2021-11-01 10:19 6401

WuXi Biologics Launches a New GMP Commercial Drug Product Facility

WuXi Biologics Completes GMP Inspection by Health Canada for Drug Substance Facility

- Successfully completed nearly 20 regulatory inspections in total, including 13 regulatory inspect...

2021-10-28 08:30 2180

WuXi Biologics Received First Manufacturing License from Japan and Completed 12 Global Regulatory Inspections in 2021 Year to Date

* Successfully completed 12 regulatory inspections so far this year WUXI, China, Sept. 1, 2021 /P...

2021-09-01 14:12 3377

WuXi Biologics Reports Strong 2021 Interim Results

* Revenue Increases by 126.7% Y-o-Y to RMB4,406.8 Million * Gross Profit Grows by 191.7% Y-o-Y t...

2021-08-23 20:59 4425

WuXi Biologics Biosafety Testing Facility Received Second EMA GMP Certificate

SUZHOU, China, Aug. 2, 2021 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a global company...

2021-08-02 20:13 4025

WuXi Biologics Received Commercial Manufacturing License from German Health Authorities for its German Drug Product Facility

* First GMP manufacturing authorization outside of China, validating WuXi Biologics' world-class ...

2021-07-26 18:00 4087

WuXi Biologics Received Commercial Manufacturing License from German Health Authorities for its German Drug Product Facility

WuXi XDC and LegoChem Biosciences Signed Memorandum of Understanding for the Development and Manufacturing of Antibody-drug Conjugates

WUXI, China and DAEJEON, South Korea, June 10, 2021 /PRNewswire/ -- WuXi XDC ("XDC"), a global CDMO...

2021-06-10 08:30 5500

WuXi Biologics and OncoC4 Establish Exclusive CDMO Partnership

SHANGHAI and ROCKVILLE, Md., May 27, 2021 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a ...

2021-05-27 08:30 6122

WuXi Biologics and WuXi STA Jointly Established WuXi XDC to Provide Fully Integrated Bioconjugate CDMO Services

WUXI, China, May 14, 2021 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a global company w...

2021-05-14 08:30 5907

WuXi Biologics Completed Three Acquisitions to Enhance its Global Network

SHANGHAI, May 7, 2021 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a global company with ...

2021-05-07 08:30 5648

WuXi Biologics Receives 2021 Asia-Pacific Bioprocessing Excellence Award from IMAPAC

SHANGHAI, April 13, 2021 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a global company wi...

2021-04-13 17:00 3676

WuXi Biologics Successfully Completed Pre-License Inspection and Routine GMP Inspection by U.S. FDA

WUXI, China, April 7, 2021 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a global company ...

2021-04-07 08:22 23358

2020 Results Record High Despite a Challenging Year

Revenue Increased by 40.9% Y-o-Y to RMB5,612 Million Gross Profit Rose by 52.7% Y-o-Y to RMB2,533 Mi...

2021-03-23 20:59 4524

WuXi Biologics to Acquire CMAB and Form Strategic Partnership with CBC Group

SUZHOU, China, March 18, 2021 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a global compa...

2021-03-18 08:59 3960

WuXi Biologics to Acquire Biologics DS and DP Manufacturing Facilities from Pfizer China

HANGZHOU, China, March 17, 2021 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a global com...

2021-03-17 08:45 4522

WuXi Vaccines Achieves Weather-Tight Construction Milestone on Main Building of Manufacturing Facility Despite COVID-19

SHANGHAI and DUNDALK, Ireland, March 16, 2021 /PRNewswire/ -- WuXi Vaccines, a world-leading vaccin...

2021-03-16 16:30 3516

Remote Pre-Approval Inspection Completed by EMA on WuXi Biologics' MFG4 Facility

WUXI, China, March 3, 2021 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a global company ...

2021-03-03 18:23 2511

WuXi Biologics Wins 2021 CMO Leadership Awards in All Six Core Categories

SHANGHAI, Feb. 25, 2021 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a global company wit...

2021-02-25 08:00 2911